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to understand patient behavior, however, the relationship between time preference 
and medication adherence is not widely understood. This study aims to summarize 
the existing literature on the association between time preference and medication 
adherence. Methods: A literature search was conducted on Medline, PsycInfo, 
PubMed and CINAHL from January 2000 to 2015 using the keywords “time prefer-
ence”, “patient compliance”, “medication adherence” and “non-adherence”. Studies 
that did not include medication adherence, lacked empirical data on time pref-
erence or assessed time preference with addictive behaviors (e.g. smoking) were 
excluded. A table summarized results, including the publication year, author, study 
design, source and findings. Results: A total of 53 articles were identified and 
nine studies were retained. Only three studies directly investigated the relation-
ship between time preference and medication adherence. Of those, studies in 2001 
examined adherence to hypertension medication in 195 older adults and adherence 
to cholesterol lowering medication in 169 adults. Findings revealed weak to no 
association between time preference and medication adherence. Conversely, a 2013 
study reported time preference as a significant predictor of medication adherence to 
asthma control medications for 47 patients with persistent asthma. ConClusions: 
Taking into account the extent to which patients will worry about adverse future 
outcomes, this review identified very few studies addressing the objective. More 
empirical research must be conducted before any conclusion can be made in 
regard to the impact of a patients’ time preference on their medication adherence 
behaviors.
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objeCtives: Medication non-adherence causes hundreds of billions of dollars in 
avoidable costs. This study sought to survey the existing medication adherence 
programs of managed care organizations (MCOs). Methods: Thirty MCOs were 
interviewed in Spring 2014 about their current and future medication adherence 
programs. 19 small (< 200,000 members) and 11 large (≥ 200,000 members) filled 
out a 19-question (excluding 6 on program characteristics) survey covering the 
strategies and methods used to improve patient adherence. Results: The MCOs 
dedicate the majority of adherence resources toward cardiovascular disease states 
but most are looking to expand to more disease states. Just two (7%) of the MCOs 
surveyed use predictive analytics to target patients for their intervention programs 
while 12 (40%) use retrospective adherence measures. 75% of MCOs are looking 
to expand their adherence programs while 60% specifically plan to use predictive 
analytics in the future. Only two (7%) only used outsourced interventions, 10 (33%) 
used in-house and 18 (60%) used some combination of the two. 20 (67%) MCOs 
used live call interventions and only 2 (7%) used text reminders. 14 small (74%) 
and 9 (82%) large MCOs used direct mail interventions. 20 (67%) of the MCOs rated 
their intervention programs to be “moderately effective.” ConClusions: Most 
MCOs prioritize adherence to cardiovascular disease medication but most are 
also interested in expanding their programs. Few MCOs use enhanced platforms 
to select patients for interventions but many plan on expanding their platforms. 
MCOs intervened to improve adherence largely through provider-centric chan-
nels and with a combination of in-house and outsourced methods. Many MCOs 
are interested in adopting a platform that identifies high-value interventions, 
like AllazoHealth, since current programs aren’t personalized and are perceived 
as ineffective.
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objeCtives: To develop and validate predictive models that identify members 
with higher risk of medication non-adherence and increased total healthcare 
cost over a 12-month period in a managed care setting. Methods: The study 
included members insured under a commercial healthcare plan who filled ≥ 1 
prescription for any of seven targeted medication classes for common chronic 
diseases between October 2010 and May 2014. Pharmacy and medical claims dur-
ing the four months before and six months after the member’s first prescription 
for a targeted medication (index date) were used to generate 85 baseline member 
variables. These variables were tested for potential model inclusion to separately 
predict medication non-adherence (proportion of days covered < 80%) and total 
healthcare costs during the 12-month follow-up period. Total costs included phar-
macy and medical costs from outpatient, emergency room, and inpatient visits. 
Members were randomized 3:1 to the development or validation samples. The 
development sample was used to estimate and refine model parameters. The 
validation sample was used to evaluate the final model’s performance based on 
c-statistic and R-squared values. Medication non-adherence was predicted using 
a logistic model. Total healthcare cost was predicted via a generalized linear model 
with a log link function and gamma distribution. Results: Among the 70,502 and 
23,505 members included in the development and validation samples, respec-
tively, baseline prevalence of medication non-adherence ranged from 37% to 73%, 
depending on the medication class. Baseline adherence and cost were the most 
important predictors. Predictive performance improved when other variables, 
such as member demographics and comorbidities, were added to the baseline 
adherence only model (c-statistic increased from 0.81 to 0.89; p< 0.0001). The cost 
model’s R-squared value was 0.43. ConClusions: The models demonstrated 
good predictive performance and could be used together to identify members 
with potential non-adherence to medications and greater healthcare costs for 
intensive clinical interventions.
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objeCtives: Thirty-two million Americans use three or more medications daily. 
Approximately 75% of patients fail to adhere to physician prescribed treatment 
regimens. The economic impact of non-adherence is estimated to cost $100 billion 
annually. Evidence suggests that the elderly are one of the largest groups contribut-
ing to the economic burden associated with non-adherence. Studies support the 
development of visual focused tools to improve adherence among older persons. 
The aim of this study was to explore the use of visual adherence tools in the hos-
pital, clinic, and home settings to determine effectiveness in improving patient 
adherence and negating hospital readmissions. Methods: Electronic databases 
such as PubMed and Google Scholar were searched from 2000 – 2014. Key words 
were “visual,” “adherence,” “elderly,” “readmissions,” and “visual adherence tool.” 
Studies were included if they were conducted outside of the U.S. since few U.S. 
studies examined visual adherence tools. A custom-designed table included year 
of publication, author, study design, intervention, findings, and sources. Results: 
A total of 24 articles and economic evaluations were retrieved. Older adults are the 
largest users of prescription medication. Whilst evidence suggests that visual medi-
cation adherence tools are useful, the tools are not being widely used in hospitals. 
This may be due to lack of knowledge about benefits. Exploration in psychology and 
marketing denotes that humans have a cognitive preference for picture-based, as 
opposed to text-based information. Reports have shown that pictorial aids expand 
recall, comprehension, and adherence. These instruments can also be particularly 
valuable for conveying dosage times, instructions on when to take medicine, as 
well as the importance of completing a course of therapy. Studies show that older 
persons prefer medication tools that focus on visual characteristics such as large 
print and simplified information. ConClusions: Several studies focused on the 
clinic and home setting, but few were hospital based. Further research is warranted.
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objeCtives: This study aimed to assess the level of medication adherence among 
patients with different non-communicable chronic diseases in Quetta Baluchistan, 
Pakistan. Methods: A cross sectional study was conducted in different non-com-
municable chronic diseases patient, visiting outpatient department in public/private 
hospitals and clinics of Quetta, Pakistan. Morisky Medication Adherence Scale (Urdu 
version) was used to collect the data. The descriptive statistics was used to present 
the demographic and disease related information. Inferential statistics was used 
to the evaluation relationship among study variables. All analyses were performed 
using SPSS 20.0. Results: A total of 505 patients with different non- chronic dis-
eases (Diabetes, Hypertension, Heart diseases, Asthma and others) were enrolled for 
the present study. The mean age of the patients was 44.9 years, majority 304 (60.2%) 
were females. There were 228, 134, 37, 32 and 74 patients for diabetes, hypertension, 
heart diseases, asthma and others respectively. There was significant statistical 
difference (p = 0.004) as present mean mediation adherence scores in different 
non-communicable chronic diseases condition (5.34, 5.05, 4.65, 4.69, 4.59 for diabe-
tes, hypertension, heart diseases, asthma and others respectively) ConClusions: 
The present study concluded that different disease conditions did affect the level 
of medication adherence, efforts should be made to provide specified health edu-
cation to improve medication adherence in different disease condition for better 
therapeutic outcome.
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objeCtives: This study aimed to assess the level of medication adherence 
among patients with non-communicable chronic diseases in Quetta Baluchistan, 
Pakistan. Methods: A cross sectional study was conducted among patients with 
non- chronic diseases, visiting outpatient department in public/private hospitals and 
clinics of Quetta city. Morisky Medication Adherence Scale (Urdu version) was used to 
collect the data. The descriptive statistics was used to present the demographic and 
disease related information. Inferential statistics was used to the evaluation relation-
ship among study variables. All analyses were performed using SPSS 20.0. Results: 
A total of 505 patients with non- chronic diseases (Diabetes, Hypertension, Heart 
diseases, Asthma and others) were enrolled for the present study. The mean age of 
the patients was 44.9 years, majority 304 (60.2%) were females. The proportions of 
diseases were; diabetes (45.1%) hypertension (26.5%) heart diseases (7.3%) asthma 
(6.3%) mainly and other (14.7%). A very small proportion of the patient 11.1% were 
having good medication adherence while 27.9% were having moderate adherence 
and 61.0% exhibited poor adherence. ConClusions: The study concluded that level 
of medication adherence among patients with non- communicable chronic disease 
was very poor, efforts should be made to identify the factors associated with non-
adherence so that level of adherence should be improved to achieve better therapeutic 
outcome.
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